Number of pages: 100 | Report Format: PDF | Published date: April 03, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
Report Attribute |
Details |
Growth Rate |
CAGR of 6.1% from 2023 to 2031 |
Base Year for Estimation |
2022 |
Forecast Period |
2023-2031 |
Historical Year |
2021 |
Segments Covered |
Application, End User and Region. |
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global ultrasound bone healing market registers a revenue CAGR of 6.1%.
Market Fundamentals
Bioabsorbable interference screws are widely used in orthopedic surgeries, including graft fixation in ACL (anterior cruciate ligament) repair. These screws secure the ACL graft in the same way that titanium screws do. However, they have the potential benefits of allowing magnetic resonance imaging (MRI), decreasing stress shielding from the gradual transfer of load during degradation, and hypothetically reducing the difficulty of revision surgery because there are no implants to remove. Numerous studies examining clinical results following the use of bioabsorbable screws have shown graft durability during screw disintegration. In August 2006, the CALAXO osteoconductive interference screw (Smith & Nephew Endoscopy, Andover, Massachusetts) was approved for clinical use. Polylactide carbonate (PLC) was used to make this bioabsorbable screw, an amorphous polymer of 65% poly (D, L-lactic-co-glycolic acid) and 35% calcium carbonate. This bioabsorbable substance was expected to have osteoconductive qualities, acting as a scaffold for fresh bone formation as it degraded. The BIOSURE HA screw was developed using PLA-HA, a bioabsorbable mixture of poly-L-lactic acid (PLA) and Hydroxyapatite (HA), naturally found in human bone. This substance stays intact until the graft adheres to the bone, at which point it interacts with bodily fluids and progressively resorbs.
Using interference screws for knee ligament reconstruction surgery is a common application. Among the numerous benefits of bioabsorbable implants over conventional metallic implants are: Because of their capacity to progressively transfer weight as they degrade, they decrease stress shielding. Bioabsorbable polymers can be designed to provide the best degradation rate for any given purpose. They decrease the need for a second operation to remove the device and may make revision surgery easier. If magnetic resonance imaging (MRI) is needed, there is also less deformation. The major drawbacks of using bioabsorbable implants are their lower mechanical strength, greater expense, and the undesirable biological reaction they may cause. Anterior cruciate ligament reconstruction surgery is a frequent treatment. On the femoral side, various devices such as screws, endo loop buttons, cross pins, and screw posts, or a mix can anchor the rebuilt graft to the bone.
Screw posts, staples, or a mix of these may also be used for tibial anchoring fasteners. Interference screws are a common option for securing the graft to the tunnel, alone or in conjunction with one of the aforementioned devices. Metal fasteners are frequently used for this. However, due to the previously mentioned benefits, bioabsorbable screws are quickly gaining popularity. The L isomer of polylactic acid is known as Poly-L-lactide (PLLA). It has a lengthy breakdown period and is hydrophobic and crystalline. Adverse consequences from their deterioration may thus appear more than three years after insertion. The most prevalent problems associated with the use of PLLA screws in ACL repair identified in the literature are intraoperative screw damage, postoperative late screw damage, and intraarticular migration.
Market Dynamics
Bioabsorbable screws have several benefits over metallic implants, including the ability to dissolve within the body, removing the need for surgical removal. These can also provide the required mechanical support for the tissue-rebuilding process. Key companies new product launches are anticipated to fuel global bio-absorbable bone screw market development. Introducing new products offers a diverse variety of bio-absorbable products for orthopedic patients to choose from, which is anticipated to contribute to the development of the global bio-absorbable market. The growing number of orthopedic patients is anticipated to drive the worldwide bio-absorbable bone screw market. However, bioabsorbable fasteners have drawbacks such as irritation, mechanical strength loss, and osteolysis. Bioabsorbable screws are used in orthopedics, sports accidents, and traumatology. These screws are used in orthopedic procedures to restore the anterior cruciate ligament, meniscal repair, and fractures. The majority of market participants are focused on customizing the material characteristics of bioabsorbable and composite materials.
However, bioabsorbable screws have some disadvantages, such as bone ingrowth characteristics and excellent in vitro and in vivo mechanical qualities. According to the biomechanical findings, the final failure loads and yield point loads of ACL screws ranged from 800-1500 N and 600-1000 N, respectively. In addition, in vivo degradation behaviors evaluations revealed that ACL fixings resorb almost completely or completely from 6 months to 2 years. However, the inclusion of bone mineral components such as Hydroxyapatite (HA), -Tricalcium Phosphate (-TCP), and Calcium Carbonate (CC) was shown to increase the rate of degradation. Incorporating biceramics into pure polymeric ACL screws may add to increased bone osteogenesity after complete screw resorption, serve as buffering agents that decrease the acidity of screw adjacent resulting from degradation of products, and improve the mechanical properties of ACL screws.
Market Ecosystem
The global bioabsorbable screws market has been analyzed from following perspective by application, end user and region.
Bioabsorbable Screws Market by Application
[78677]
Based on application, the global bioabsorbable screws market has been segmented into the lower extremity bone screw system, upper extremity bone screw system, spinal bone screw system, and others.
Lower extremity fractures are expected to account for the majority of lower limb fragility fractures, but they also include thigh bone (femoral) fractures, pelvic fractures, shin bone (tibia) fractures, fractures around the knee, and fractures in the foot. Fasteners are used to join two pieces using simple drilling and riveting tools. Orthopedic screws are used in the lower limb to treat OCDs, fractures, osteotomies, and arthrodesis of the tarsals, metatarsals, and phalanges. Screws are used on the lower limb, anywhere from the hip to the feet, and it typically happens after an accident or a fall from standing. Bioabsorbable screws have a proven efficiency in treating lower extremity fractures. The high incidence of lower limb fractures and the greater need for surgery in treating complex fractures support the high demand for the bioabsorbable screws market. On the other hand, the spinal segment is anticipated to expand rapidly due to an increase in spine-related disorders among individuals due to shifting lifestyles. Furthermore, the prevalence of at-birth spinal defects in the form of musculoskeletal disorders or developmental defects supports the growing demand for bioabsorbable screws in the spinal segment.
Bioabsorbable Screws Market by End User
Based on end users, the global bioabsorbable screws market has been segmented into bone screw system for hospitals, bone screw system for clinics, bone screw system for ambulatory surgical centers.
Hospitals account for the majority of the share because hospitals, including ambulatory surgery facilities, treat the majority of individuals with orthopedic illnesses, followed by clinics. Patients who choose to have surgery in an ASC come on the day of their operation, have their surgery in a fully equipped operating room, and recuperate under the supervision of highly experienced nurses, all without the need for hospitalization.
Bioabsorbable Screws Market by Region
Based on region, the global bioabsorbable screws market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Because of the growing number of orthopedic patients in the region, North America is anticipated to dominate the global bioabsorbable screw market. According to a study by the American Academy of Orthopedic Surgery, more than 10 million individuals in the United States were suffering from orthopedic ailments in 2019. Over the forecast period, the growing number of orthopedic patients is anticipated to drive worldwide bioabsorbable screw market growth. The increase in the amount of hospital-based surgeries has increased the demand for bone screw devices. Growing government financing and private investment have boosted market demand in the healthcare sector for bone screw devices. The market for bioabsorbable screw devices in hospitals will expand as robotic technology becomes more widely used in healthcare operations. Along with the conventional orthopedic indications, bioabsorbable implants, including screws, have increasing use in sports medicine and traumatology.
The market for bio-absorbable screws in Europe is anticipated to expand significantly due to the introduction of novel orthopedic products. For example, Smith & Nephew Plc., a business that creates, designs, and distributes medical devices globally, introduced Biosure Regenesorb in 2017. Biosure Regenesorb is a bio-composite substance with an open architecture form that promotes bone growth. It is used for graft fixation and can be evaluated in limited regions, assisting with graft-to-bone incorporation. Graft-to-bone interaction is critical in the mending and remodeling processes. Thus, the introduction of new products that aid in the mending process is anticipated to drive the development of the Europe bio-absorbable bone screw market.
Competitive Landscape
Some of prominent market players in the global bioabsorbable screws market include,
Strategic Development
Bioabsorbable interference screws are widely used in orthopedic operations, including graft fixation in ACL (anterior cruciate ligament) repair. These screws secure the ACL graft in the same way that titanium screws do. However, they have the added potential benefits of allowing magnetic resonance imaging (MRI), decreasing stress shielding from the gradual transfer of load during degradation, and theoretically reducing the difficulty of revision surgery because there are no implants to remove.
The lower extremity fractures led the global bioabsorbable screws market.
Europe is the key growth region in the global bioabsorbable screws market.
Key companies' new product launches are anticipated to fuel the growing number of orthopedic patients, along with improving clinical evidence are anticipated to drive the worldwide bio-absorbable bone screw market.
Some prominent players in the global bioabsorbable screws market include Smith & Nephew Plc., Zimmer Biomet, DePuy Synthes Companies, among others.
*Insights on financial performance are subject to the availability of information in the public domain